These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16510175)

  • 1. The racial disparity in outcomes in endometrial cancer: could this be explained on a molecular level?
    Schimp VL; Ali-Fehmi R; Solomon LA; Hammoud A; Pansare V; Morris RT; Munkarah AR
    Gynecol Oncol; 2006 Sep; 102(3):440-6. PubMed ID: 16510175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
    Pansare V; Munkarah AR; Schimp V; Haitham Arabi M; Saed GM; Morris RT; Ali-Fehmi R
    Mod Pathol; 2007 Jan; 20(1):35-43. PubMed ID: 17099695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome.
    Morrison C; Miecznikowski J; Darcy KM; Dolce JM; Kandel E; Erwin DO; Liu S; Shepherd L; Cohn D; McMeekin DS; Block AW; Nowak NJ; Maxwell L
    Genes Chromosomes Cancer; 2010 Sep; 49(9):791-802. PubMed ID: 20607851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?
    Cote ML; Ruterbusch JJ; Ahmed Q; Bandyopadhyay S; Alosh B; Abdulfatah E; Seward S; Morris R; Ali-Fehmi R
    Gynecol Oncol; 2014 Apr; 133(1):38-42. PubMed ID: 24680590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.
    Ebru T; Fulya OP; Hakan A; Vuslat YC; Necdet S; Nuray C; Filiz O
    Int Braz J Urol; 2017; 43(3):440-454. PubMed ID: 27583351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of age at diagnosis on racial disparities in endometrial cancer patients.
    Tarney CM; Tian C; Wang G; Dubil EA; Bateman NW; Chan JK; Elshaikh MA; Cote ML; Schildkraut JM; Shriver CD; Conrads TP; Hamilton CA; Maxwell GL; Darcy KM
    Gynecol Oncol; 2018 Apr; 149(1):12-21. PubMed ID: 28800945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database.
    Morris GJ; Naidu S; Topham AK; Guiles F; Xu Y; McCue P; Schwartz GF; Park PK; Rosenberg AL; Brill K; Mitchell EP
    Cancer; 2007 Aug; 110(4):876-84. PubMed ID: 17620276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.
    Long B; Liu FW; Bristow RE
    Gynecol Oncol; 2013 Sep; 130(3):652-9. PubMed ID: 23707671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race-driven survival differential in women diagnosed with endometrial cancers in the USA.
    Horne ZD; Teterichko SR; Glaser SM; Wegner RE; Hasan S; Crafton SM; Miller EM; Krivak TC; Viswanathan A; Olawaiye AB; Sukumvanich P; Beriwal S
    Int J Gynecol Cancer; 2020 Dec; 30(12):1893-1901. PubMed ID: 32847996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.
    Alkushi A; Lim P; Coldman A; Huntsman D; Miller D; Gilks CB
    Int J Gynecol Pathol; 2004 Apr; 23(2):129-37. PubMed ID: 15084841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in treatment and outcome between African-American and white women with endometrial cancer.
    Randall TC; Armstrong K
    J Clin Oncol; 2003 Nov; 21(22):4200-6. PubMed ID: 14615448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
    Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
    J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
    Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
    Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling of endometrial cancers from African-American and Caucasian women.
    Ferguson SE; Olshen AB; Levine DA; Viale A; Barakat RR; Boyd J
    Gynecol Oncol; 2006 May; 101(2):209-13. PubMed ID: 16380157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
    Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
    Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hospital volume on racial disparities and outcomes for endometrial cancer.
    Buskwofie A; Huang Y; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2018 May; 149(2):329-336. PubMed ID: 29506862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia contributes to development of recurrent endometrial carcinoma.
    Pijnenborg JM; Wijnakker M; Hagelstein J; Delvoux B; Groothuis PG
    Int J Gynecol Cancer; 2007; 17(4):897-904. PubMed ID: 17359291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.
    Bateman NW; Dubil EA; Wang G; Hood BL; Oliver JM; Litzi TA; Gist GD; Mitchell DA; Blanton B; Phippen NT; Tian C; Zahn CM; Cohn DE; Havrilesky LJ; Berchuck A; Shriver CD; Darcy KM; Hamilton CA; Conrads TP; Maxwell GL
    Cancer; 2017 Oct; 123(20):4004-4012. PubMed ID: 28654152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of programmed death-ligand 1 and hypoxia-inducible factor-1α proteins in endometrial carcinoma.
    Tawadros AIF; Khalafalla MMM
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1063-S1069. PubMed ID: 30539847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.